Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (11-20 of 372) with videos related to

Pageof 38
Sort By:
Pharmacology & Therapeutics|August 25, 2020
TGFβ-Directed Therapeutics: 2020Beverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Newer cytotoxic agents: attacking cancer broadlyBeverly A Teicher
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapyB A Teicher
Molecular Cancer Therapeutics|October 17, 2006
Tumor models for efficacy determinationBeverly A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
Role of angiogenesis in the response to anticancer therapiesB A Teicher
International Journal of Oncology|January 5, 2007
Newer vascular targets: endosialin (review)Beverly A Teicher
Biochemical Pharmacology|October 6, 2010
Antiangiogenic agents and targets: A perspectiveBeverly A Teicher
Biochemical Pharmacology|December 7, 2007
Next generation topoisomerase I inhibitors: Rationale and biomarker strategiesBeverly A Teicher
Oncology Reports|July 4, 2013
Perspective: Opportunities in recalcitrant, rare and neglected tumorsBeverly A Teicher
Expert Opinion on Drug Discovery|March 14, 2013
Human tumor xenografts and mouse models of human tumors: re-discovering the modelsBeverly A Teicher
Pageof 38

Showing results (11-20 of 372) with videos related to

Sort By:
Pageof 38
Pharmacology & Therapeutics|August 25, 2020
TGFβ-Directed Therapeutics: 2020Beverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Newer cytotoxic agents: attacking cancer broadlyBeverly A Teicher
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapyB A Teicher
Molecular Cancer Therapeutics|October 17, 2006
Tumor models for efficacy determinationBeverly A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
Role of angiogenesis in the response to anticancer therapiesB A Teicher
International Journal of Oncology|January 5, 2007
Newer vascular targets: endosialin (review)Beverly A Teicher
Biochemical Pharmacology|October 6, 2010
Antiangiogenic agents and targets: A perspectiveBeverly A Teicher
Biochemical Pharmacology|December 7, 2007
Next generation topoisomerase I inhibitors: Rationale and biomarker strategiesBeverly A Teicher
Oncology Reports|July 4, 2013
Perspective: Opportunities in recalcitrant, rare and neglected tumorsBeverly A Teicher
Expert Opinion on Drug Discovery|March 14, 2013
Human tumor xenografts and mouse models of human tumors: re-discovering the modelsBeverly A Teicher
Pageof 38